Prediction of cardiovascular risk: validation of a non-laboratory and a laboratory-based score in a Brazilian community-based cohort of the PURE studyResearch in context

Summary: Background: Risk scores are essential tools for implementing cardiovascular disease (CVD) prevention. Validating risk scores considering regional diversities and disparities is critical for reducing the burden of CVD on global morbidity and mortality. We aimed to validate two cardiovascula...

Full description

Saved in:
Bibliographic Details
Main Authors: Gustavo Bernardes de Figueiredo Oliveira, Rafael Amorim Belo Nunes, Lucas Bassolli de Oliveira Alves, Precil Diego Miranda de Menezes Neves, Victor Augusto Hamamoto Sato, Ana Heloisa Kamada Triboni, Haliton Alves de Oliveira Júnior, Priscila Raupp da Rosa, Maria Luz Díaz, Jose Patricio Lopez-Jaramillo, Fernando Lanas, Philip Joseph, Álvaro Avezum
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:The Lancet Regional Health. Americas
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667193X25000195
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850195206680346624
author Gustavo Bernardes de Figueiredo Oliveira
Rafael Amorim Belo Nunes
Lucas Bassolli de Oliveira Alves
Precil Diego Miranda de Menezes Neves
Victor Augusto Hamamoto Sato
Ana Heloisa Kamada Triboni
Haliton Alves de Oliveira Júnior
Priscila Raupp da Rosa
Maria Luz Díaz
Jose Patricio Lopez-Jaramillo
Fernando Lanas
Philip Joseph
Álvaro Avezum
author_facet Gustavo Bernardes de Figueiredo Oliveira
Rafael Amorim Belo Nunes
Lucas Bassolli de Oliveira Alves
Precil Diego Miranda de Menezes Neves
Victor Augusto Hamamoto Sato
Ana Heloisa Kamada Triboni
Haliton Alves de Oliveira Júnior
Priscila Raupp da Rosa
Maria Luz Díaz
Jose Patricio Lopez-Jaramillo
Fernando Lanas
Philip Joseph
Álvaro Avezum
author_sort Gustavo Bernardes de Figueiredo Oliveira
collection DOAJ
description Summary: Background: Risk scores are essential tools for implementing cardiovascular disease (CVD) prevention. Validating risk scores considering regional diversities and disparities is critical for reducing the burden of CVD on global morbidity and mortality. We aimed to validate two cardiovascular risk scores (laboratory and non-laboratory-based) to predict major adverse cardiovascular events in the Brazilian cohort of the PURE study. Methods: We validated two risk scores derived from the INTERHEART study, the non-laboratory INTERHEART risk score (NL-IHRS) and the laboratory fasting cholesterol INTERHEART risk score (FC-IHRS) using data from 4623 (urban areas) and 1415 (rural areas) participants without CVD in the Brazilian cohort of the PURE study enrolled in 2004 and 2005 and followed up to September 2021. The endpoint was major cardiovascular events (MACE), defined as the composite of myocardial infarction, stroke, heart failure, or death from cardiovascular causes. We evaluated the model performance of IHRS through c-statistic and calibration methods. Findings: After a mean follow-up of 8.8 years (range, 0.28–15.1 years), there were 312 cardiovascular events, corresponding to an incidence rate of 0.58% per year (0.56% per year in urban versus 0.64% per year in rural areas). For the NL-IHRS, the c-statistic was 0.69 (95% confidence interval, CI, 0.66–0.72) in the overall cohort, 0.68 (95% CI, 0.64–0.72) in the urban cohort, and 0.72 (95% CI, 0.66–0.78) in the rural cohort. C-statistic values for the recalibrated FC-IHRS were 0.71 (95% CI, 0.67–0.74), 0.71 (95% CI, 0.67–0.75), and 0.70 (95% CI, 0.64–0.76) in the overall, urban, and rural cohorts, respectively. Interpretation: In this Brazilian community-based prospective cohort, both NL-IHRS and FC-IHRS-based models performed with reasonable discriminative accuracy on the risk estimation of long-term risk of major CVD. A non-laboratory-based CVD risk score may be instrumental in Brazilian communities with limited access to medical resources. Funding: Population Health Research Institute, Novartis Biociências S.A.
format Article
id doaj-art-d7a446456a4943fd8fc394fa6cdf5266
institution OA Journals
issn 2667-193X
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series The Lancet Regional Health. Americas
spelling doaj-art-d7a446456a4943fd8fc394fa6cdf52662025-08-20T02:13:48ZengElsevierThe Lancet Regional Health. Americas2667-193X2025-03-014310100910.1016/j.lana.2025.101009Prediction of cardiovascular risk: validation of a non-laboratory and a laboratory-based score in a Brazilian community-based cohort of the PURE studyResearch in contextGustavo Bernardes de Figueiredo Oliveira0Rafael Amorim Belo Nunes1Lucas Bassolli de Oliveira Alves2Precil Diego Miranda de Menezes Neves3Victor Augusto Hamamoto Sato4Ana Heloisa Kamada Triboni5Haliton Alves de Oliveira Júnior6Priscila Raupp da Rosa7Maria Luz Díaz8Jose Patricio Lopez-Jaramillo9Fernando Lanas10Philip Joseph11Álvaro Avezum12International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, BrazilInternational Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, BrazilInternational Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, BrazilInternational Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, BrazilInternational Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, BrazilInternational Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, BrazilInternational Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, BrazilNovartis Biociências S.A, São Paulo, BrazilInstituto Cardiovascular de Rosario, Rosario, ArgentinaMasira Research Institute, Medical School, Universidad de Santander, Bucaramanga, ColombiaUniversidad de la Frontera, Temuco, ChilePopulation Health Research Institute, McMaster University, Hamilton, CanadaInternational Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil; Population Health Research Institute, McMaster University, Hamilton, Canada; Corresponding author. International Research Center, Hospital Alemão Oswaldo Cruz, Av. Paulista, 500, 5º andar, São Paulo, SP 01310-000, Brazil.Summary: Background: Risk scores are essential tools for implementing cardiovascular disease (CVD) prevention. Validating risk scores considering regional diversities and disparities is critical for reducing the burden of CVD on global morbidity and mortality. We aimed to validate two cardiovascular risk scores (laboratory and non-laboratory-based) to predict major adverse cardiovascular events in the Brazilian cohort of the PURE study. Methods: We validated two risk scores derived from the INTERHEART study, the non-laboratory INTERHEART risk score (NL-IHRS) and the laboratory fasting cholesterol INTERHEART risk score (FC-IHRS) using data from 4623 (urban areas) and 1415 (rural areas) participants without CVD in the Brazilian cohort of the PURE study enrolled in 2004 and 2005 and followed up to September 2021. The endpoint was major cardiovascular events (MACE), defined as the composite of myocardial infarction, stroke, heart failure, or death from cardiovascular causes. We evaluated the model performance of IHRS through c-statistic and calibration methods. Findings: After a mean follow-up of 8.8 years (range, 0.28–15.1 years), there were 312 cardiovascular events, corresponding to an incidence rate of 0.58% per year (0.56% per year in urban versus 0.64% per year in rural areas). For the NL-IHRS, the c-statistic was 0.69 (95% confidence interval, CI, 0.66–0.72) in the overall cohort, 0.68 (95% CI, 0.64–0.72) in the urban cohort, and 0.72 (95% CI, 0.66–0.78) in the rural cohort. C-statistic values for the recalibrated FC-IHRS were 0.71 (95% CI, 0.67–0.74), 0.71 (95% CI, 0.67–0.75), and 0.70 (95% CI, 0.64–0.76) in the overall, urban, and rural cohorts, respectively. Interpretation: In this Brazilian community-based prospective cohort, both NL-IHRS and FC-IHRS-based models performed with reasonable discriminative accuracy on the risk estimation of long-term risk of major CVD. A non-laboratory-based CVD risk score may be instrumental in Brazilian communities with limited access to medical resources. Funding: Population Health Research Institute, Novartis Biociências S.A.http://www.sciencedirect.com/science/article/pii/S2667193X25000195Cardiovascular diseaseRisk scoreRisk factorsBrazilValidation study
spellingShingle Gustavo Bernardes de Figueiredo Oliveira
Rafael Amorim Belo Nunes
Lucas Bassolli de Oliveira Alves
Precil Diego Miranda de Menezes Neves
Victor Augusto Hamamoto Sato
Ana Heloisa Kamada Triboni
Haliton Alves de Oliveira Júnior
Priscila Raupp da Rosa
Maria Luz Díaz
Jose Patricio Lopez-Jaramillo
Fernando Lanas
Philip Joseph
Álvaro Avezum
Prediction of cardiovascular risk: validation of a non-laboratory and a laboratory-based score in a Brazilian community-based cohort of the PURE studyResearch in context
The Lancet Regional Health. Americas
Cardiovascular disease
Risk score
Risk factors
Brazil
Validation study
title Prediction of cardiovascular risk: validation of a non-laboratory and a laboratory-based score in a Brazilian community-based cohort of the PURE studyResearch in context
title_full Prediction of cardiovascular risk: validation of a non-laboratory and a laboratory-based score in a Brazilian community-based cohort of the PURE studyResearch in context
title_fullStr Prediction of cardiovascular risk: validation of a non-laboratory and a laboratory-based score in a Brazilian community-based cohort of the PURE studyResearch in context
title_full_unstemmed Prediction of cardiovascular risk: validation of a non-laboratory and a laboratory-based score in a Brazilian community-based cohort of the PURE studyResearch in context
title_short Prediction of cardiovascular risk: validation of a non-laboratory and a laboratory-based score in a Brazilian community-based cohort of the PURE studyResearch in context
title_sort prediction of cardiovascular risk validation of a non laboratory and a laboratory based score in a brazilian community based cohort of the pure studyresearch in context
topic Cardiovascular disease
Risk score
Risk factors
Brazil
Validation study
url http://www.sciencedirect.com/science/article/pii/S2667193X25000195
work_keys_str_mv AT gustavobernardesdefigueiredooliveira predictionofcardiovascularriskvalidationofanonlaboratoryandalaboratorybasedscoreinabraziliancommunitybasedcohortofthepurestudyresearchincontext
AT rafaelamorimbelonunes predictionofcardiovascularriskvalidationofanonlaboratoryandalaboratorybasedscoreinabraziliancommunitybasedcohortofthepurestudyresearchincontext
AT lucasbassollideoliveiraalves predictionofcardiovascularriskvalidationofanonlaboratoryandalaboratorybasedscoreinabraziliancommunitybasedcohortofthepurestudyresearchincontext
AT precildiegomirandademenezesneves predictionofcardiovascularriskvalidationofanonlaboratoryandalaboratorybasedscoreinabraziliancommunitybasedcohortofthepurestudyresearchincontext
AT victoraugustohamamotosato predictionofcardiovascularriskvalidationofanonlaboratoryandalaboratorybasedscoreinabraziliancommunitybasedcohortofthepurestudyresearchincontext
AT anaheloisakamadatriboni predictionofcardiovascularriskvalidationofanonlaboratoryandalaboratorybasedscoreinabraziliancommunitybasedcohortofthepurestudyresearchincontext
AT halitonalvesdeoliveirajunior predictionofcardiovascularriskvalidationofanonlaboratoryandalaboratorybasedscoreinabraziliancommunitybasedcohortofthepurestudyresearchincontext
AT priscilarauppdarosa predictionofcardiovascularriskvalidationofanonlaboratoryandalaboratorybasedscoreinabraziliancommunitybasedcohortofthepurestudyresearchincontext
AT marialuzdiaz predictionofcardiovascularriskvalidationofanonlaboratoryandalaboratorybasedscoreinabraziliancommunitybasedcohortofthepurestudyresearchincontext
AT josepatriciolopezjaramillo predictionofcardiovascularriskvalidationofanonlaboratoryandalaboratorybasedscoreinabraziliancommunitybasedcohortofthepurestudyresearchincontext
AT fernandolanas predictionofcardiovascularriskvalidationofanonlaboratoryandalaboratorybasedscoreinabraziliancommunitybasedcohortofthepurestudyresearchincontext
AT philipjoseph predictionofcardiovascularriskvalidationofanonlaboratoryandalaboratorybasedscoreinabraziliancommunitybasedcohortofthepurestudyresearchincontext
AT alvaroavezum predictionofcardiovascularriskvalidationofanonlaboratoryandalaboratorybasedscoreinabraziliancommunitybasedcohortofthepurestudyresearchincontext